Quality Systems Guidance Uses Manufacturing Consent Decrees As Model
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA expects the draft guidance will pave the way toward revising the GMP regulations. The agency plans to apply its quality systems initiative to several internal areas including warning letters and recalls.